June 23, 2017 — Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.
Imaging technologies are a major part of evaluating new patient treatments, allowing clinicians and sponsors to detect diseases, monitor outcomes and determine therapy responses. Median Technologies, a services provider of image interpretation and management in oncology trials, will leverage Medidata Medical Imaging to transition its legacy imaging study management systems to a single digital environment, gaining seamless access to configurable and intelligent image workflows, while still maintaining global regulatory standards.
"Our collaboration with Medidata will not only ease the management of images during clinical drug trials- it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes," said Jeanne Hecht, Median Technologies' chief operating officer.
Medidata Medical Imaging provides superior workflow management and flexibility of image resources, according to the company, working seamlessly with proprietary technologies like Median. The collaboration will provide Median with the highest level of control and access to image data and performance metrics, while enabling automatic edit checks and de-identification.
For more information: www.mdsol.com
April 25, 2024 
